AUTONOMIC DRUGS Flashcards
- The parasympathetic preganglionic fibers leave the CNS through
these cranial nerves
A. 1, 5, 9, 10
B. 10, 3, 7, 9
C. 3, 7, 5, 10
D. 2, 7, 10, 5
E. None of the above
ANSWER: B. 10, 3, 7, 9. The parasympathetic preganglionic
fibers leave the CNS through the cranial nerves (CN 3:
Oculomotor, CN 7: Facial, CN 9: Glossopharyngeal, and CN 10:
Vagus).
- The primary receptor type of autonomic ganglia
A. Cholinergic: nicotinic
B. Cholinergic: muscarinic
C. Adrenergic: beta 1
D. Adrenergic: beta 2
E. Dopaminergic: D1-5?
ANSWER: A. Cholinergic: nicotinic.
- Most thoracolumbar preganglionic fibers are?
A. Short
B. Long
C. In networks
D. Connected to organs
E. None of the above
ANSWER: A. Short. Most thoracic and lumbar sympathetic
preganglionic fibers are short and terminate in ganglia located
in the paravertebral chains that lie on either side of the spinal
column. Most of the remaining sympathetic preganglionic fibers
are somewhat longer and terminate in prevertebral ganglia,
which lie in front of the vertebrae, usually on the ventral surface
of the aorta.
- Cholinergic drugs act on receptors normally stimulated by?
A. Norepinephrine
B. Acetylcholine
C. Epinephrine
D. Dopamine
E. None of the above
ANSWER: B. Acetylcholine
- It catalyzes the rate-limiting step in catecholamine biosynthesis
A. L-amino acid decarboxylase
B. Dopamine beta-hydroxylase
C. Phenylethanolamine-N-methyl transferase
D. Tyrosine hydroxylase
E. Dopa decarboxylase
ANSWER: D. Tyrosine hydroxylase catalyzes the rate-limiting
step in the biosynthesis of catecholamines, the conversion of
Tyrosine to Dopa.
- Parasympathetic direct cardiac effects?
A. Decrease heart rate, decrease contractility
B. Increase heart rate, increase contractility
C. Increase AV nodal conduction velocity
D. Decrease heart rate, increase contractility
E. Increase heart rate, decrease contractility
ANSWER: A. Decrease heart rate, decrease contractility
- Drug that prevents the storage of acetylcholine in synaptic
vesicle?
A. Botulinum toxin
B. Vesamicol
C. Metyrosine
D. Tetrodotoxin
E. None of the above
ANSWER: B. Vesamicol. Acetylcholine (ACh) is transported into
the storage vesicle by a vesicle-associated transporter (VAT),
which can be inhibited by vesamicol.
- The rate-limiting step in catecholamine biosynthesis can be
blocked by?
A. Botulinum Toxin
B. Hemicholinium
C. Synaptosomal nerve-associated membrane proteins
D. Metyrosine
E. Vesamicol
ANSWER: D. Metyrosine.
see figure
- The acetylcholine vesicle release process can be blocked by?
A. Hemicholinium
B. Vesamicol
C. Botulinum toxin
D. Vesicle-associated membrane proteins
E. Synaptosomal nerve-associated membrane proteins
ANSWER: C. Botulinum toxin. The resulting increase in
intracellular calcium causes fusion of vesicles with the surface
membrane and exocytotic expulsion of acetylcholine and
cotransmitters into the junctional cleft. This step can be blocked
by botulinum toxin.
- In the cytoplasm, acetylcholine is synthesized from choline and
Acetyl-CoA by what enzymes?
A. Acetylcholinesterase
B. Choline acetyltransferase
C. Vesicle associated transporter
D. Phenylethanolamine-N-methyltransferase
E. None of the above
ANSWER: B. Choline acetyltransferase. Acetylcholine (ACh) is
synthesized in the cytoplasm from acetyl-CoA and choline
through the catalytic action of the enzyme choline
acetyltransferase (ChAT).
- This drug can block the reuptake of noradrenergic transmitters
into the nerve terminal
A. Reserpine
B. Cocaine
C. Guanethidine
D. Metyrosine
E. Bretylium
ANSWER: B. Cocaine. NET can be inhibited by cocaine and
certain antidepressant drugs, resulting in an increase of
norepinephrine activity in the synaptic cleft.
- Rate limiting step in acetylcholine synthesis
A. Availability of acetate
B. Choline acetate activity
C. Choline uptake
D. Vesicular protein synthesis
E. Acetylcholinesterase activity
ANSWER: A. Availability of acetate
- Inhibits choline transfer into cholinergic vesicles
A. Atropine
B. Bretylium
C. Reserpine
D. Vesamicol
E. All of the above
ANSWER: D. Vesamicol
- Influx of this ion promotes fusion between axoplasmic
membrane and nearby vesicles
A. Potassium
B. Chloride
C. Calcium
D. Sodium
E. All of the above
ANSWER: C. Calcium. Release of transmitters occurs when
voltage-sensitive calcium channels in the terminal membrane
are opened, allowing an influx of calcium. The resulting increase
in intracellular calcium causes fusion of vesicles with the surface
membrane and exocytotic expulsion of acetylcholine and cotransmitters into the junctional (synaptic) cleft.
- Which is not a choline ester?
A. Arecoline
B. Acetylcholine
C. Bethanechol
D. Carbachol
E. Methacholine
ANSWER: A. Arecoline. Acetylcholine and methacholine are
acetic acid esters of choline and β-methylcholine, respectively.
Carbachol and bethanechol are carbamic acid esters of the same
alcohols.
- Which among the following choline ester drugs is the most
susceptible to hydrolysis by the enzyme cholinesterase?
A. Arecoline
B. Carbachol
C. Acetylcholine
D. Metacholine
E. Bethanecol
ANSWER: C. Acetylcholine.
- Which among the following choline ester drugs has the most
muscarinic action?
A. Acetylcholine
B. Bethanecol
C. Carbachol
D. Methacholine
E. Arecoline
ANSWER: D. Methacholine. See above table.
- This direct-acting cholinomimetic drug is used for postoperative
ileus and urinary retention?
A. Pilocarpine
B. Carbachol
C. Arecoline
D. Bethanecol
E. Nicotine
ANSWER: Bethanecol
- Effects of direct-acting cholinoceptor stimulants except?
A. Sinoatrial node: positive chronotropy
B. Bronchial muscles: bronchoconstriction
C. Sphincter muscle of iris: miosis
D. Gastrointestinal tract motility: increase
E. All are correct
ANSWER: A. Sinoatrial node: positive chronotropy
- The ff are indirect acting cholinomimetic drugs except
A. Acetylcholine
B. Neostigmine
C. Echothiophate
D. Edrophonium
E. Carbaryl
ANSWER: A. Acetylcholine is a direct-acting cholinomimetic
drug.
- The following are effects of anticholinesterase except?
A. Miosis
B. Bradycardia
C. Reduced muscle contraction
D. Hypersalivation
E. All are correct
ANSWER: C. Reduced muscle contraction. Anticholinesterases
aka cholinesterase inhibitors block the degradation of
acetylcholine and thereby prolong its action. Because the
primary action is to amplify the actions of endogenous
acetylcholine, the effects are similar (but not always identical)
to the effects of the direct-acting cholinomimetic agonists.
- Long-term therapy for myasthenia gravis is usually
accomplished with?
A. Pyridostigmine
B. Physostigmine
C. Neostigmine
D. Edrophonium
E. Echothiophate
ANSWER: A. Pyridostigmine. Edrophonium is for acute
treatment only. While both pyridostigmine and neostigmine are
both used for treatment of myasthenia gravis, pyridostigmine
has a longer duration of action (4-6 hours).
- This anticholinesterase organophosphate drug was used as an
ophthalmic solution for treating glaucoma?
A. Neostigmine
B. Echothiophate
C. Edrophonium
D. Physostigmine
E. Pyridostigmine
ANSWER: B. Echothiophate. See above table.
- Which of the following reversible cholinesterase inhibitor is not
used in the treatment of myasthenia gravis?
A. Physostigmine
B. Pyridostigmine
C. Neostigmine
D. Edrophonium
E. All drugs can be used
ANSWER: A. Physostigmine is used for anticholinergic
poisoning. Refer to #23 table.